Rumors about the possibility of antiviral drugs from Mark & Co. MRK,
And Rizbak biotherapeutics is hot enough that there is already a political debate over who is responsible for the lack of access to debate.
However, this rumor is significantly missing in the world financial markets. That’s right, the third-stage trial showed that Molnupirvi’s mild or moderate covid-1 reduced the risk of hospitalization or death for patients with about 50%, increased Mark’s stock by 11%, but the broader market response was not great.
Two plays for reopening – Invesco Dynamic Laser and Entertainment PJ,
And US Global Jets Jets,
Exchange-traded funds প্রত্য everyone saw a bounce the day before it sank, airlines ETFs are now lower after the news. Similarly, the Nasdaq Composite Comp,
Those who have benefited from the tendency to stay at home have more or less stayed in that place.
Analysts at UK hedge-fund operator Man Group noted that there are already licensing agreements with Indian generic drug manufacturers for Molnupirvir and that other pharmaceuticals are working on their own oral treatments.
“In our view, this development has great potential to fully revive the global economy. At 700 700 per course, it’s not cheap, but much cheaper than the cost of hospital treatment. Similarly, since it specifically targets the patients most at risk, it is likely to reduce the political cost of reopening the drug, which has kept infection levels unchanged but greatly reduced hospital admissions and deaths, ”James Terrer and Ed Cole said in a note.
Valuable like 11 other auto manufacturers, including General Motors GM,
And Toyota TM,
Combined (Chrysler owner Stellantis STLA,
The numbers are off the list to work with, valued at ১ 1 billion.) Tesla chief executive Elon Musk responded to the tweet with an eye and tongue emoji.
Earnings season begins with results from banking giant JPMorgan Chase JPM,
Fund Management Titan Blackrock BLK,
And Delta Air Lines DAL,
The September Consumer Price Index is due to be released, 2 minutes after the last Federal Open Market Committee meeting.
The iPhone 1 is cutting production targets because it can’t get enough microchips from supplier Broadcom AVGIO,
And Texas Instruments TXN,
According to Bloomberg News.
The software giant grew its Frankfurt trade after expanding its full-year outlook.
US stock futures ES00,
Higher after the third consecutive fall for the S&P 500 SPX
Yield at 10 year Treasury TMUBMUSD10Y,
As Blue Origin prepares to send “Star Trek” actor William Shutter into space, the Washington Post, owned by Jeff Bezos, reports on the alleged ineffective “bro culture” at the Bezos-owned space company.
Speaking of space, a strange radio signal is confusing astronomers.
Listen to the best new ideas in Money Podcasts.
The need to know starts early and is updated up to the opening hour, but sign up here to deliver it once in your email box. The emailed version will be sent at half past one in the morning.
Want more for the day ahead? Sign up for the Baron Daily Morning Briefing for investors with exclusive comments from Baron and Marketwatch authors.